IgM acts as a first-line defense and compensates for IgA deficiency via secretory IgM (sIgM), agglutinating microbes and moderating dysbiosis, though it cannot fully substitute IgA’s anti-inflammatory functions. The gene discussed is CD79A; the disease is hyperinsulinemic hypoglycemia, familial, 4.